Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial

作者：Chloe Orkin, Jean‐Michel Molina, Eugènia Negredo, José Ramón Arribas, Joseph Gathe, Joseph J. Eron, Erika Van Landuyt, Erkki Lathouwers, Veerle Hufkens, Romana Petrovic, Simon Vanveggel, Magda Opsomer, F. Ajana, José Ramón Arribas, Joseph I. Bailey, Paul Benson, Juan Berenguer, Laveeza Bhatti, Anders Blaxhult, Indira Brar, U. Fritz Bredeek, Cynthia Brinson, Jason Brunetta, José L. Casado, Amanda Clarke, Brian Conway, Laurent Cotte, Gordon E Crofoot, David Cunningham, Jerome De Vente, S De Wit, E DeJesus, C Dietz, Robin Dretler, Joe Eron, Jan Fehr, Franco Felizarta, Carl J. Fichtenbaum, Leo Flamholc, Éric Florence, MJ Galindo, Joel E. Gallant, Jacek Gąsiorowski, JM Gatell, Joseph Gathe, BG Gazzard, PM Girard, Magnus Gisslén, Félix Gutiérrez, MDM Gutierrez, D Hagins, Waldemar Halota, S Henn, WK Henry, Andrzéj Horban, Gregory Huhn, JA Iribarren, Mamta K. Jain, MA Johnson, Christine Katlama, Marina B. Klein, Hernando Knobel, Christopher Lucasti, Claudia Martorell, C McDonald, Anthony Mills, J-M Molina, Javier O Morales-Ramirez, Karam Mounzer, Michel Moutschen, Daniel Murphy, Ronald Nahass, Eugènia Negredo, H Olivet, Chloe Orkin, Olayemi Osiyemi, Ignacio Valero, Anna Piekarska, Juan A. Pineda, Daniel Podzamczer, Isabelle Poizot‐Martin, J Portilla Sogorb, Frank A. Post, D Prelutsky, Federico Pulido, Anita Rachlis, François Raffi, Moti Ramgopal, Bruce Rashbaum, Andri Rauch, D. Rey, Jacques Reynes, C Ricart, Gary Richmond, Antonio Rivero, Peter Ruane, I Santos Gil, A Scarsella, Anita Scribner, Stephen D. Shafran, Peter Shalit, David Shamblaw, Jihad Slim, Marcel Stoeckle, K. Tashima, Elina Teicher, Anders Thalme, Andrew Ustianowski, Eric Van Wijngaerden, Linos Vandekerckhove, Bernard Vandercam, Gene W. Voskuhl, Sharon Walmsley, D Ward, Laura Waters, Aimee Wilkin, Anita Witor, Yazdan Yazdanpanah · 发表于：The Lancet HIV · 年份：2017 · DOI：10.1016/s2352-3018(17)30179-0 · 被引用次数：97 · 研究领域：HIV/AIDS drug development and treatment、HIV/AIDS Research and Interventions、HIV-related health complications and treatments